Featured Research

from universities, journals, and other organizations

'Multi-Hit' mouse to help unravel mutations that can give rise to cancer

Date:
August 6, 2012
Source:
Veterinärmedizinische Universität Wien
Summary:
Despite a huge amount of research effort, the molecular mechanisms that underlie the transition from a “normal” cell to a cancerous cell are only poorly understood.  After the discovery of the first cancer-causing genes or oncogenes and the finding that they are mutated forms of normal cellular genes, it was widely believed that a single mutation was enough to cause cancer.  Subsequent research, however, has revealed that most cancers only develop as a result of several mutations.  A bewildering variety of combinations of mutations have been shown to have the potential to give rise to cancer.  Finding out which combinations are dangerous has to date been largely a matter of trial and error, but this should change with the development of the 'Multi-Hit' mouse -- a tool to identify mutations that really do collaborate to cause cancer.

Despite a huge amount of research effort, the molecular mechanisms that underlie the transition from a “normal” cell to a cancerous cell are only poorly understood.  After the discovery of the first cancer-causing genes or oncogenes and the finding that they are mutated forms of normal cellular genes, it was widely believed that a single mutation was enough to cause cancer.  Subsequent research, however, has revealed that most cancers only develop as a result of several mutations.  A bewildering variety of combinations of mutations have been shown to have the potential to give rise to cancer.  Finding out which combinations are dangerous has to date been largely a matter of trial and error, but this should change with the development of a tool to identify mutations that really do collaborate to cause cancer.

Robert Eferl and colleagues announce the new “Multi-Hit” mouse in the current issue of the journal Nature Methods.  The work is one result of a longstanding collaboration between many institutions in the Vienna area coordinated by Mathias Müller of the University of Veterinary Medicine, Vienna.

It is now generally accepted that cancer only arises if two or more genes are mutated.  To date, learning which combinations of mutations cause cancer has represented an extremely laborious endeavour but the development of the “Multi-Hit” mouse looks set to change this.  The group of Robert Eferl at the Ludwig Boltzmann Institute for Cancer Research, Vienna has taken advantage of the Cre-recombinase system to generate random combinations of correctly and incorrectly oriented oncogenes (or tumour suppressor genes, genes whose inactivation may contribute to the development of cancer) and investigated which of the combinations caused tumours.

They tested their system on the well-known Ras protein, which has been shown to be mutated in many different cancers.  Ras mutations were thought to cause cancer only if the so-called Raf gene was also mutated but it has more recently been proposed that changes in other genes, such as those encoding the RALGEF (Ral guanine nucleotide exchange factor), MAPK (mitogen-activated protein kinase) or PI3K (phosphatitylinositol-3-kinase) proteins, may also combine with mutated Ras proteins to cause tumour development.  The researchers found that mutations in Ras alone did not cause tumours to develop, while following activation of the Cre recombinase (and thus random activation – by flipping – of the genes under study) all mice developed cancer. 

Examination of the tumours showed that in most of them all three genes had been activated, although activation of the P13K gene alone (and in very rare cases of one of the other two genes alone) could also give rise to cancer.  In other words, the most rapidly proliferating, and thus most life-threatening, tumours were associated with activation of all three of the genes investigated.  This indicates that all the genes are somehow contributing to the development of cancer, which means that drugs targeting any or all of them could play a part in treatment.

Eferl, now at the Institute for Cancer Research & Comprehensive Cancer Center of the Medical University of Vienna, is naturally excited by the results.  “Our work on Ras has given important clues to possible therapeutic strategies.  But this was really only a proof of principle.  More importantly, the results show that our Multi-Hit mouse can indeed be used to study interactions between gene mutations.  This should make it much easier for us to understand how cancer arises and what we can do to treat it.”

The work was partially funded by a grant from the Austrian Science Fund to Robert Eferl and Mathias Müller as part of the Priority Research Programme “JakStat” coordinated by Mathias Müller at the Vetmeduni Vienna.


Story Source:

The above story is based on materials provided by Veterinärmedizinische Universität Wien. Note: Materials may be edited for content and length.


Journal Reference:

  1. Monica Musteanu, Leander Blaas, Rainer Zenz, Jasmin Svinka, Thomas Hoffmann, Beatrice Grabner, Daniel Schramek, Hans-Peter Kantner, Mathias Müller, Thomas Kolbe, Thomas Rülicke, Richard Moriggl, Lukas Kenner, Dagmar Stoiber, Josef Martin Penninger, Helmut Popper, Emilio Casanova, Robert Eferl. A mouse model to identify cooperating signaling pathways in cancer. Nature Methods, 2012; DOI: 10.1038/nmeth.2130

Cite This Page:

Veterinärmedizinische Universität Wien. "'Multi-Hit' mouse to help unravel mutations that can give rise to cancer." ScienceDaily. ScienceDaily, 6 August 2012. <www.sciencedaily.com/releases/2012/08/120806085134.htm>.
Veterinärmedizinische Universität Wien. (2012, August 6). 'Multi-Hit' mouse to help unravel mutations that can give rise to cancer. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2012/08/120806085134.htm
Veterinärmedizinische Universität Wien. "'Multi-Hit' mouse to help unravel mutations that can give rise to cancer." ScienceDaily. www.sciencedaily.com/releases/2012/08/120806085134.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) — The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) — The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) — The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) — In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins